The emerging approach of this peptide represents a major development in the care of diabetes mellitus type 2. Different to existing medications, tirzepatide impacts two pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – resulting in enhanced blood sugar regulation and anticipated weight loss. Scientists are exploring its … Read More